INTRODUCTION
Enteric fever is one of the most common causes of pyrexia of unknown origin (PUO) in most parts of the world. It includes typhoid fever caused by Salmonella Typhi and paratyphoid fever caused by S. Paratyphi A, B and C. An estimated 600,000 deaths occur annually throughout the world due to enteric fever. It continues to be a major public health problem in developing countries and the mortality is as high as 30%. Isolation of Salmonella species occurs throughout the year. S. Typhi and S. Paratyphi A are the predominant types of Salmonella responsible for enteric fever in India. 1 Chloramphenicol was considered the gold standard anti-microbial for the treatment of typhoid fever after its introduction in 1948. 2 Amoxicillin and co-trimoxazole were the effective alternatives till the development of "multidrug resistant (MDR) strains" (resistant to ampicillin, chloramphenicol and co-trimoxazole -ACCo) towards the end of 1980s and 1990s. 3 Due to increasing frequency of antibiotic resistance, the use of chloramphenicol, amoxicillin and co-trimoxazole have become infrequent and quinolones have become the first line of treatment for typhoid fever. However, in recent years, there have been several reports indicating the re-emergence of susceptibility to drugs used in the past, such as ampicillin and trimethoprim. Therefore, the present study was done to determine the antimicrobial susceptibility pattern of S. Typhi & S. Paratyphi A in our region.
MATERIAL & METHODS
A total of 35,854 blood specimens obtained from patients suffering from PUO or septicemia during the study period (January 2010 -December 2011) were processed using the automated blood culture systems (BACTEC 9240/ Bac T Alert 3D). The samples were inoculated in blood culture bottles and incubated in the system. When the bottle was flagged positive by the system, subculture was done on 5% sheep blood agar & MacConkey's agar and a smear was prepared. Initial identification of the organism was carried out on the basis of colony morphology and Gram's stain. The final identification and antimicrobial susceptibility testing was done by using fully automated systems (Microscan Walkaway/ Vitek 2). In addition the confirmation of Salmonella spp. was carried out using specific antisera procured from CRI, Kasauli.
RESULTS
Out of a total of 35,854 blood samples processed, 5,234 (14.6%) were positive for various organisms. Out of these, Salmonella spp. was isolated from 363 (6.93%) blood samples. Of these, 281 (77.4%) were identified as S .Typhi and 82 (22.6%) as S. Paratyphi A. Year wise distribution of Salmonella isolates is depicted in Figure I . Table I shows the antibiotic sensitivity pattern of S. 
DISCUSSION
Enteric fever is an important public health problem in many underdeveloped and developing countries. S. Typhi continues to be the predominant pathogen in enteric fever but infections with S. Paratyphi A are also on rise. In the present study, a 28.5% increase in S. Typhi isolates was observed whereas an increase of 39% was observed in S. Paratyphi A in the year 2011 in comparison to 2010. Similar trend has been observed by Gupta et al 4 in Chandigarh and Tankhiwale et al 5 in Nagpur.
Resistance to commonly used antibiotics has been reported from different parts of India. Yashawanth et al 6 reported a sensitivity of 98.7% and 92.7% to ampicillin for S. Typhi and S. Paratyphi A in Mangalore. Similarly, in the present study 99.3% of S. Typhi and 100% of S. Paratyphi A isolates were susceptible to ampicillin (MIC < 8µg/ml). However, as per Gupta et al 4 S. Paratyphi A isolates were less susceptible to ampicillin (69.2%) in Chandigarh. In a separate study by Verma et al, 7 sensitivity of S. Typhi & S. Paratyphi A was 67% and 71.5% respectively for ampicillin.
There has been increase in cases of clinical failure after the administration of ciprofloxacin to patients with enteric fever. Prajapati et al 8 reported a decreased susceptibility to ciprofloxacin, 86.6% for S. Typhi and 51.3% for S. Paratyphi A. Similarly, Lakshmi et al 9 reported a sensitivity of 83% and 70% to S. Typhi and S Paratyphi A respectively. In contrast, Tankhiwale et al, 5 Nagpur, India, reported that 100% of the S. Paratyphi A isolates were sensitive to ciprofloxacin and Verma et al reported a sensitivity of 90.6% and 91.2% to S. Typhi and S. Paratyphi A respectively. 7 In the present study, 100% of S. Paratyphi A isolates & 98.2 % of S. Typhi isolates were found to be sensitive to ciprofloxacin & levofloxacin (MIC <1µg/ml & <2µg/ml respectively).
Ceftriaxone, cefotaxime, and (oral) cefixime are effective for treatment of MDR enteric fever, including nalidixic acid resistant and fluoroquinolone-resistant strains. In the present study, all the Salmonella isolates were susceptible to ceftazidime, however one of the S. Paratyphi A isolates was found resistant to ceftriaxone. Various studies from other parts of India have also reported 100% sensitivity to 3 rd generation cephalosporins, 4-6,10,11 whereas resistance to these have been reported by Verma et al. 7 Prompt administration of appropriate antibiotic therapy prevents severe complications of enteric fever and results in decreased case-fatality rate. Though multi drug resistant are being reported from various parts of India, but in our region the Salmonella isolates are still susceptible to the commonly used drugs. It is advisable to do continuous surveillance of antimicrobial susceptibility pattern of isolates as to make rational use of antibiotics in the management of enteric fever cases.
